Chromosomal analyses in previously reported cases of coexistent sickle cell disease and myeloid malignancies revealed complex cytogenetic abnormalities, including TP53 mutations, deletions of 5q-, 7q-, 17p-, trisomy 8, and KMT2A rearrangements [15]. This evidence concerns the gene KMT2A and sickle cell disease.